Insys Therapeutics reaches $150m agreement to settle opioid marketing case
August 9, 2018Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma
The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas
August 8, 2018Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma
AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
Stem cells could ‘reset’ immune system in Crohn’s disease patients
August 8, 2018Research and Development Crohn’s disease, Stem cells, crohn's disease, trials
A clinical trial led by researchers at Queen Mary University, London is looking into ways in which patients with Crohn’s …
MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak
August 8, 2018Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma
MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …
Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%
August 8, 2018Research and Development Spark Therapeutics, haemophilia, pharma
Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …
Drugs should be preferred first-choice treatment for ADHD
August 8, 2018Research and Development ADHD, adults, amphetmines, children, prescription, ritalin
Ritalin and other amphetamines should be the preferred first-choice medications for the short-term treatment of ADHD, according to a study …
GSK appoint HSBC director Iain Mackay as new CFO
August 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc
British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …
Ironwood returns US Zurampic rights to AstraZeneca, announces operational cuts
August 7, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Ironwood, Zurampic, gout, pharma
Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …
FDA announces policy shift to encourage new opioid addiction treatments
August 7, 2018Manufacturing and Production FDA, deaths, opioid crisis, overdose, policy
The US Food and Drug Administration (FDA) have announced that it is altering the way it evaluates a drug’s ability …
Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller
August 7, 2018Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma
The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
MHRA sets out Brexit implementation period plan
August 7, 2018Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period
The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
Fentanyl-related deaths spike in England and Wales
August 7, 2018Manufacturing and Production fentanyl, heroin, ons, opioid crisis, opioids, statistics
Deaths linked to the powerful opioid fentanyl have increased by 30% in England and Wales. Figures from the Office for …
Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros
August 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda
The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Regeneron Pharma and Bluebird bio announce immune cell collaboration
August 6, 2018Sales and Marketing Cancer, Regeneron, Shares, bluebird, collaboration, t cells, t-cells
Regeneron Pharmaceuticals have announced that they will collaborate with the Massachusetts-based gene therapy specialist Bluebird bio in an effort to …
Enough talk: Action is required to achieve parity in biotech
August 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women
Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …
Jazz Pharmaceuticals to expand Irish workforce across Dublin, Athlone sites
August 6, 2018Manufacturing and Production, Sales and Marketing Dublin, Ireland, jazz pharmaceuticals, pharma
Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its bases in its home country …
Pfizer to consider stockpiling medicines in preperation for no-deal Brexit
August 6, 2018Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling
Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …
England’s top GP resigns over imflammatory online comments
August 6, 2018Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma
England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …
Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest
August 6, 2018Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby
The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
